Lung and Heart USG for Predicting Weaning in Neurosurgical Patients
NCT ID: NCT03580993
Last Updated: 2018-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2018-01-30
2018-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, we evaluate parameters of ultrasonographic evaluation of lung aeration and cardiac function in neurosurgical patients undergoing weaning and their ability to predict successful weaning and extubation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Lung Ultrasound in Predicting Weaning Outcomes
NCT02022839
Comparison of Two Methods for Assessing Cough Capacity in Intensive Care Unit After Cardiac Surgery
NCT03983044
Respiratory Weaning Following Cardiac Surgery.
NCT02821429
Ultrasound Study of the Diaphragm Evolution Under ECMO
NCT03736239
Ultrasound Diagnostic for Diaphragmatic Dysfunction in Reanimation
NCT02883465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A neurosurgical patient is different from any other post-operative or critically ill patients. Their altered cerebral physiology, specific goals of therapy, varied response to usual management protocols, put them in a different league whole together. The primary aim of care for these patients is to detect and prevent any secondary neurological insult while supporting systemic and neurological homeostasis. Hypoxia and hypercarbia are factors which need to be absolutely avoided while caring for such patients. A good proportion of these patients will have respiratory instability, airway compromise and altered sensorium, which makes them prone to hypoxia and hypercarbia. To avoid these secondary insults to the neurological system, endotracheal intubation and mechanical ventilation is instituted in patients who are at high risk. Mechanical ventilation is continued until the patient is clinically stabilized and primary neurological damage has been taken care of. Subsequently the transition from control ventilation to spontaneous ventilation begins
The weaning process from mechanical ventilation involves sequential reduction of ventilatory parameters, assessment of readiness of the patient for extubation and when all these criterias are acceptable, then finally extubation. Daily, meticulous evaluation of clinical and neurological conditions and completion of spontaneous breathing trial (SBT) should be considered in order to recognize and facilitate the process of withdrawal of the mechanical ventilation. Extubation is considered as a success when the ventilator prosthesis is removed after the patient passed the SBT and there is no need for reinstitution of the MV in the next 48 hours. The entire process of weaning can be categorised as a six step process:
1. Taking care of the primary event
2. Deciding whether to start weaning
3. Assessing the readiness to wean
4. Spontaneous breathing trial (SBT)
5. Extubation
6. Assessment of probable reintubation6
Several parameters have been instituted for assessing the capability of weaning. These include: Rapid Shallow Breathing Index, which is the ratio of respiratory frequency to tidal volume (RSBI=f/VT), Pulmonary gas exchange (like: PaO2/FiO2, PaCO2), Vital Capacity (VC), Minute Ventilation and Static Compliance. Weaning may not always have a successful outcome. Difficult weaning may in fact be due to different or mixed etiologies, the diagnosis of which requires meticulous monitoring of various physiologic and objective parameters. Assessment of lung aeration by ultrasonography is rapidly gaining significance in weaning protocol. Apart from lung ultrasonography, the role of transthoracic echocardiography in successfully predicting weaning capability have been investigated in the recent times. Cardiac related weaning failure may be due to systolic LV dysfunction or isolated diastolic dysfunction. By this study we are trying to evaluate the scope of ultrasonography in detection of lung aeration and cardiac systolic and diastolic function in mechanically ventilated neurosurgical patients undergoing weaning; and whether they can be used as a good diagnostic tool to detect those who are likely to fail weaning in this specific subset of patient population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SBT Completers
Those patients who successfully complete a spontaneous breathing trial of 2 hours.
Lung Ultrasound
Lung ultrasound and Echocardiography used to derive parameters for prediction of successful SBT.
SBT Non-completers
Those patients who fail to complete a spontaneous breathing trial of 2 hours.
Lung Ultrasound
Lung ultrasound and Echocardiography used to derive parameters for prediction of successful SBT.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung Ultrasound
Lung ultrasound and Echocardiography used to derive parameters for prediction of successful SBT.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. All patients whose underlying disease that required intubation was considered reversed or stabilised by the attending physician, rendering them eligible for spontaneous breathing trials.
Exclusion Criteria
2. Pregnancy
3. Patients having a GCS score of less than 8
4. Those having a pre weaning PaO2/ FiO2 ratio of less than 200
5. Severe ICU acquired neuromyopathy
6. Patients with lower cranial nerve involvement
7. Tracheostomised patients
8. Patients having high spinal cord lesions (above T8)
9. Presence of thoracostomy, pneumothorax or pneumomediastinum
10. Presence of rib fractures
11. Presence of pleural effusion
12. Patients having severe left ventricular dysfunction (LVEF \< 35%)
13. Patients with planned prophylactic noninvasive ventilation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health and Neuro Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dhritiman Chakrabarti
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Mental Heath and Neurosciences
Bangalore, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IEC(BS & NS DIV)/2017-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.